Global Medical Fluid Bags Market – Europe is expected to account for higher market share of more than 67% driven by geriatric patient pool coupled with increasing incidences of age related chronic diseases such as cancer, kidney disorders and skin diseases – Global Market Analysis and Forecast 2019 – 2026

Global Medical Fluid Bags Market – Europe is expected to account for higher market share of more than 67% driven by geriatric patient pool coupled with increasing incidences of age related chronic diseases such as cancer, kidney disorders and skin diseases – Global Market Analysis and Forecast 2019 – 2026

Market Scenario

Global Medical Fluid Bags Market is expected to grow at a CAGR of 7% to reach US$ XX million in 2026.Global Medical Fluid Bags Market,  By RegionThe growth is coupled with the Rising prevalence of chronic diseases such as heart, kidney and liver disorders, cancer, diabetes, and anemia worldwide will serve to be a high impact rendering factor for Global Medical Fluid Bags Market growth. High incidences of gastrointestinal diseases among geriatric population such as bowel obstruction, Crohn’s disease, and gastroschisis will fuel the demand for medical fluid bags. Treatment of these diseases requires hospitalization to facilitate administration of drugs and nutrition thereby increasing the industry growth over the forecast period. The number of surgical procedures is increasing across the globe owing to the growing number of healthcare centers in developed as well as emerging economies and advancements in healthcare facilities. Moreover, favorable reimbursement policies in regions such as North America and Europe will encourage patients to undergo expensive treatments. Growing patient base undergoing surgical procedures for the treatment of various diseases will serve to be a high impact rendering factor that will drive the Global Medical Fluid Bags Market growth during the forthcoming years. Europe Medical Fluid Bags market dominated the overall sector and is expected to maintain its dominance during the study period. The Global Medical Fluid Bags Market is driven by a geriatric patient pool coupled with increasing incidences of age-related chronic diseases such as cancer, kidney disorders, and skin diseases. Favorable reimbursement policies and the growing number of healthcare centers will fuel the regional growth during the forthcoming years. Asia Pacific medical fluid bags market is estimated to witness the fastest growth rate during the forecast period owing to the increasing prevalence of chronic diseases. Growing disposable income and developments in healthcare facilities in the emerging economies will boost the regional growth. Moreover, the increasing number of premature births leads to the necessity of providing total parenteral nutrition to preterm babies thereby accelerating the demand for intravenous bags throughout the forecast period. Drain bags segment of Global Medical Fluid Bags Market dominated the industry in 2017 expected to dominate during the forecast period owing to its wide applications in various surgical procedures. The rising prevalence of kidney related diseases such as diabetes, hypertension and renal failure among the geriatric population base leading to an increasing number of surgical procedures will further accelerate the industry growth over the forecast period. The objective of the report is to present comprehensive Global Medical Fluid Bags Market Device Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Medical Fluid Bags Market Device Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Medical Fluid Bags Market Device Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Medical Fluid Bags Market Device Market  North America for Asia Pacific make the report investor’s guide.

Global Medical Fluid Bags Market Segmentation:

• Global Medical Fluid Bags Market, By Product

o Blood bags o Intravenous bags o Drain bags o Enema bags o Biohazard disposable bag o Breast milk bag o Reagent bag o Dialysis bags

•Global Medical Fluid Bags Market, By Material

o PVC compounds o Polyolefins o Thermoplastic elastomers o Thermoplastic polyurethanes

•Global Medical Fluid Bags Market, By End-Use

o Hospitals o Blood banks o Clinics o Homecare settings o Diagnostic centers

•Global Medical Fluid Bags Market,  By Region

• North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia

Key Players in the Medical Fluid Bags Market

• B. Braun,Terumo, • Baxter • Fresenius Kabi, • Hospira, • Kawasumi Laboratories, • Kraton, MacoPharma, • Pall Corporation, • Westfield Medical, • Amsino, • Coloplast, • Renolit, • C.R.Bard, • Thermo Fisher, • Sippex, • Smiths Medical, • Technoflex, • ConvaTec, • among others. What information is covered in the Report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017 Global Dental Sterilization Devices Market 

Table of Contents

Global Medical Fluid Bags Market

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Medical Fluid Bags Market overview 2.1.1. By Product 2.1.2. By End-Use 2.1.3. By Materials Chapter 3 Global Medical Fluid Bags Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Demand for Ostomy Medical Specialty Bags 3.2.1.2. Rising Awareness Regarding Adopting Safe Healthcare Measures for Prevention of Disease Transmission 3.2.2. Market Restrains 3.2.2.1. Availability of Alternative Means 3.3. Market share analysis 3.3.1. By Product 3.3.2. By End-Use 3.3.3. By Materials 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Medical Fluid Bags Market, By Products 4.1. Key segment trends 4.2. Blood bags 4.2.1. Market size, by region, 2013 - 2024 4.3. Intravenous bags 4.3.1. Market size, by region, 2019-2026 4.4. Drain bags 4.4.1. Market size, by region, 2019-2026 4.5. Enema bags 4.5.1. Market size, by region, 2019-2026 4.6. Biohazard disposable bag 4.6.1. Market size, by region, 2019-2026 4.7. Breast milk bag 4.7.1. Market size, by region, 2019-2026 4.8. Reagent bag 4.8.1. Market size, by region, 2019-2026 4.9. Dialysis bags 4.9.1. Market size, by region, 2019-2026 4.9.2. Key Trends in Global Medical Fluid Bags Market Chapter 5 Medical Fluid Bags Market, By Materials 5.1. Key segment trends 5.2. PVC compounds 5.2.1. Market size, by region, 2013 - 2024 5.3. Polyolefins 5.3.1. Market size, by region, 2019-2026 5.4. Thermoplastic elastomers 5.4.1. Market size, by region, 2019-2026 5.5. Thermoplastic polyurethanes 5.5.1. Market size, by region, 2019-2026 Chapter 6 Medical Fluid Bags Market, By End-Use 6.1. Key segment trends 6.2. Hospitals 6.2.1. Market size, by region, 2013 - 2024 6.3. Blood banks 6.3.1. Market size, by region, 2019-2026 6.4. Clinics 6.4.1. Market size, by region, 2019-2026 6.5. Homecare settings 6.5.1. Market size, by region, 2019-2026 6.6. Diagnostic centers 6.6.1. Market size, by region, 2019-2026 Chapter 7 Medical Fluid Bags Market, By Region 7.1. Key regional trends 7.2. North America 7.2.1. Market size, by country, 2019-2026 7.2.2. Market size, by end-use, 2019-2026 7.2.3. Market size, by products, 2019-2026 7.2.4. Market size, by material, 2019-2026 7.2.5. U.S. 7.2.5.1. Market size, by end-use, 2019-2026 7.2.5.2. Market size, by products, 2019-2026 7.2.5.3. Market size, by material, 2019-2026 7.2.6. Canada 7.2.6.1. Market size, by end-use, 2019-2026 7.2.6.2. Market size, by products, 2019-2026 7.2.6.3. Market size, by material, 2019-2026 7.3. Europe 7.3.1. Market size, by country, 2019-2026 7.3.2. Market size, by end-use, 2019-2026 7.3.3. Market size, by products, 2019-2026 7.3.4. Market size, by material, 2019-2026 7.3.5. Germany 7.3.5.1. Market size, by end-use, 2019-2026 7.3.5.2. Market size, by products, 2019-2026 7.3.5.3. Market size, by material, 2019-2026 7.3.6. UK 7.3.6.1. Market size, by end-use, 2019-2026 7.3.6.2. Market size, by products, 2019-2026 7.3.6.3. Market size, by material, 2019-2026 7.3.7. France 7.3.7.1. Market size, by end-use, 2019-2026 7.3.7.2. Market size, by products, 2019-2026 7.3.7.3. Market size, by material, 2019-2026 7.3.8. Spain 7.3.8.1. Market size, by end-use, 2019-2026 7.3.8.2. Market size, by products, 2019-2026 7.3.8.3. Market size, by material, 2019-2026 7.3.9. Italy 7.3.9.1. Market size, by end-use, 2019-2026 7.3.9.2. Market size, by products, 2019-2026 7.3.9.3. Market size, by material, 2019-2026 7.4. Asia Pacific 7.4.1. Market size, by country, 2019-2026 7.4.2. Market size, by end-use, 2019-2026 7.4.3. Market size, by products, 2019-2026 7.4.4. Market size, by material, 2019-2026 7.4.5. India 7.4.5.1. Market size, by end-use, 2019-2026 7.4.5.2. Market size, by products, 2019-2026 7.4.5.3. Market size, by material, 2019-2026 7.4.6. China 7.4.6.1. Market size, by end-use, 2019-2026 7.4.6.2. Market size, by products, 2019-2026 7.4.6.3. Market size, by material, 2019-2026 7.4.7. Japan 7.4.7.1. Market size, by end-use, 2019-2026 7.4.7.2. Market size, by products, 2019-2026 7.4.7.3. Market size, by material, 2019-2026 7.4.8. Australia 7.4.8.1. Market size, by end-use, 2019-2026 7.4.8.2. Market size, by products, 2019-2026 7.4.8.3. Market size, by material, 2019-2026 7.5. Latin America 7.5.1. Market size, by country, 2019-2026 7.5.2. Market size, by end-use, 2019-2026 7.5.3. Market size, by products, 2019-2026 7.5.4. Market size, by material, 2019-2026 7.5.5. Argentina 7.5.5.1. Market size, by end-use, 2019-2026 7.5.5.2. Market size, by products, 2019-2026 7.5.5.3. Market size, by material, 2019-2026 7.5.6. Brazil 7.5.6.1. Market size, by end-use, 2019-2026 7.5.6.2. Market size, by products, 2019-2026 7.5.6.3. Market size, by material, 2019-2026 7.5.7. Mexico 7.5.7.1. Market size, by end-use, 2019-2026 7.5.7.2. Market size, by products, 2019-2026 7.5.7.3. Market size, by material, 2019-2026 7.6. Middle East and Africa 7.6.1. Market size, by country, 2019-2026 7.6.2. Market size, by end-use, 2019-2026 7.6.3. Market size, by products, 2019-2026 7.6.4. Market size, by material, 2019-2026 7.6.5. South Africa 7.6.5.1. Market size, by end-use, 2019-2026 7.6.5.2. Market size, by products, 2019-2026 7.6.5.3. Market size, by material, 2019-2026 7.6.6. Saudi Arabia 7.6.6.1. Market size, by end-use, 2019-2026 7.6.6.2. Market size, by products, 2019-2026 7.6.6.3. Market size, by material, 2019-2026 Chapter 8 Consolidations 8.1. Mergers and Acquisitions 8.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 8.3. Patent Analysis 8.4. Key players 8.4.1. Amsino, B. 8.4.1.1. Company overview 8.4.1.2. Key financials 8.4.1.3. Product landscape 8.4.1.4. Strategic initiatives 8.4.1.5. SWOT analysis 8.4.2. Braun 8.4.2.1. Company overview 8.4.2.2. Key financials 8.4.2.3. Product landscape 8.4.2.4. Strategic initiatives 8.4.2.5. SWOT analysis 8.4.3. Baxter 8.4.3.1. Company overview 8.4.3.2. Key financials 8.4.3.3. Product landscape 8.4.3.4. Strategic initiatives 8.4.3.5. SWOT analysis 8.4.4. C.R.Bard 8.4.4.1. Company overview 8.4.4.2. Key financials 8.4.4.3. Product landscape 8.4.4.4. Strategic initiatives 8.4.4.5. SWOT analysis 8.4.5. Coloplast 8.4.5.1. Company overview 8.4.5.2. Key financials 8.4.5.3. Product landscape 8.4.5.4. Strategic initiatives 8.4.5.5. SWOT analysis 8.4.6. Charles River Laboratories International, Inc. 8.4.6.1. Company overview 8.4.6.2. Key financials 8.4.6.3. Product landscape 8.4.6.4. Strategic initiatives 8.4.6.5. SWOT analysis 8.4.7. ConvaTec 8.4.7.1. Company overview 8.4.7.2. Key financials 8.4.7.3. Product landscape 8.4.7.4. Strategic initiatives 8.4.7.5. SWOT analysis 8.4.8. Sartorius AG 8.4.8.1. Company overview 8.4.8.2. Key financials 8.4.8.3. Product landscape 8.4.8.4. Strategic initiatives 8.4.8.5. SWOT analysis 8.4.9. Asahi Kasei Medical Co., Ltd. 8.4.9.1. Company overview 8.4.9.2. Key financials 8.4.9.3. Product landscape 8.4.9.4. Strategic initiatives 8.4.9.5. SWOT analysis 8.4.10. Wipak 8.4.10.1. Company overview 8.4.10.2. Key financials 8.4.10.3. Product landscape 8.4.10.4. Strategic initiatives 8.4.10.5. SWOT analysis 8.4.11. Sartorius 8.4.11.1. Company overview 8.4.11.2. Key financials 8.4.11.3. Product landscape 8.4.11.4. Strategic initiatives 8.4.11.5. SWOT analysis 8.4.12. Danaher 8.4.12.1. Company overview 8.4.12.2. Key financials 8.4.12.3. Product landscape 8.4.12.4. Strategic initiatives 8.4.12.5. SWOT analysis 8.4.13. Fresenius Kabi 8.4.13.1. Company overview 8.4.13.2. Key financials 8.4.13.3. Product landscape 8.4.13.4. Strategic initiatives 8.4.13.5. SWOT analysis 8.4.14. Smiths Medical 8.4.14.1. Company overview 8.4.14.2. Key financials 8.4.14.3. Product landscape 8.4.14.4. Strategic initiatives 8.4.14.5. SWOT analysis 8.4.15. Technoflex 8.4.15.1. Company overview 8.4.15.2. Key financials 8.4.15.3. Product landscape 8.4.15.4. Strategic initiatives 8.4.15.5. SWOT analysis 8.4.16. Terumo 8.4.16.1. Company overview 8.4.16.2. Key financials 8.4.16.3. Product landscape 8.4.16.4. Strategic initiatives 8.4.16.5. SWOT analysis 8.4.17. Thermo Fisher 8.4.17.1. Company overview 8.4.17.2. Key financials 8.4.17.3. Product landscape 8.4.17.4. Strategic initiatives 8.4.17.5. SWOT analysis 8.4.18. Vonco 8.4.18.1. Company overview 8.4.18.2. Key financials 8.4.18.3. Product landscape 8.4.18.4. Strategic initiatives 8.4.18.5. SWOT analysis 8.4.19. Westfield Medical 8.4.19.1. Company overview 8.4.19.2. Key financials 8.4.19.3. Product landscape 8.4.19.4. Strategic initiatives 8.4.19.5. SWOT analysis 8.4.20. Kawasumi Laboratories 8.4.20.1. Company overview 8.4.20.2. Key financials 8.4.20.3. Product landscape 8.4.20.4. Strategic initiatives 8.4.20.5. SWOT analysis 8.4.21. Kraton 8.4.21.1. Company overview 8.4.21.2. Key financials 8.4.21.3. Product landscape 8.4.21.4. Strategic initiatives 8.4.21.5. SWOT analysis 8.4.22. Maco Pharma 8.4.22.1. Company overview 8.4.22.2. Key financials 8.4.22.3. Product landscape 8.4.22.4. Strategic initiatives 8.4.22.5. SWOT analysis 8.4.23. Pall Corporation 8.4.23.1. Company overview 8.4.23.2. Key financials 8.4.23.3. Product landscape 8.4.23.4. Strategic initiatives 8.4.23.5. SWOT analysis 8.4.24. Renolit 8.4.24.1. Company overview 8.4.24.2. Key financials 8.4.24.3. Product landscape 8.4.24.4. Strategic initiatives 8.4.24.5. SWOT analysis 8.4.25. Sippex 8.4.25.1. Company overview 8.4.25.2. Key financials 8.4.25.3. Product landscape 8.4.25.4. Strategic initiatives 8.4.25.5. SWOT analysis

About This Report

Report ID11003
Category Healthcare
Published Dateoct 2019
No of Pages301
Contact Us
Call Now